Assessment of Venous Thrombus Characteristics in Renal Cell Carcinoma Patients Through Volumetric Computed Tomography First-Order Radiomic Features - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Venous Thrombus Characteristics in Renal Cell Carcinoma Patients Through Volumetric Computed Tomography First-Order Radiomic Features

  • By

  • Paweł Kowal

  • Krzysztof Ratajczyk

  • Wiktor Bursiewicz

  • Maciej Trzciniecki

  • Karolina Marek-Bukowiec

  • Joanna Rogala

  • Yulian Mytsyk

  • February 4, 2026

Share

Clinical Scorecard: Assessment of Venous Thrombus Characteristics in Renal Cell Carcinoma Patients Through Volumetric Computed Tomography First-Order Radiomic Features

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients diagnosed with renal cell carcinoma exhibiting venous tumor thrombus requiring surgical intervention.
Care Setting

Key Highlights

  • Add specific statistics for 3-year and 5-year OS rates.

Guideline-Based Recommendations

Diagnosis

    Management

    • Perform radical nephrectomy with thrombectomy for localized RCC with VTT, considering tumor size and extent.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Surgical approaches are complex and require careful preoperative imaging assessment, considering potential complications.

        Clinical Best Practices

        • Utilize advanced imaging techniques such as 3D modeling and machine learning for accurate thrombus characterization.

        Related Resources & Content

        Original Source(s)

        Assessment of Venous Thrombus Characteristics in Renal Cell Carcinoma Patients Through Volumetric Computed Tomography First-Order Radiomic Features

        • by Paweł Kowal, Krzysztof Ratajczyk, Wiktor Bursiewicz, Maciej Trzciniecki, Karolina Marek-Bukowiec, Joanna Rogala, Yulian Mytsyk

        • February 4, 2026

        Related Content

        Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma

        Analyzing Prognostic and Immune Characteristics of Kidney Renal Clear Cell Carcinoma through Mitochondria-Associated Membranes and Identifying DNM1L as a Potential Target for Therapy Using Machine Learning Techniques

        2026 AACR Renal Cell Carcinoma Highlights

        The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

        • June 17, 2026

        • 1 min